Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
SynopsisP

US adopts bar codes for drug products

Milan Korcok
CMAJ May 25, 2004 170 (11) 1657; DOI: https://doi.org/10.1503/cmaj.1040617
Milan Korcok
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Prescription drugs, biological products and some over-the-counter medications in the US will now be labelled with supermarket-style bar codes — a change the US Food and Drug Administration (FDA) predicts will prevent 500 000 medication errors over the next 20 years.

“By giving health care providers a way to check medications and dosages quickly, we create an opportunity to reduce the risks of medication errors that can seriously harm patients,” says Tommy Thompson, secretary of US Health and Human Services (HHS).

Manufacturers, repackers, relabellers and private label distributors will have to put bar codes on new products within 60 days of an FDA approval. They have 2 years to comply with the requirement for products already on the market.

Each bar code must contain the product's National Drug Code identifier, but may include additional information. Blood products intended for transfusion will include the facility identifier, the lot number relating to the donor, the product code and the donor's blood type and Rh factor. Standardized bar codes will also be required on prescription drug products sold in retail pharmacies. Physicians' drug samples will be exempt.

In a typical dispensing situation, a health care worker will scan the patient's bar coded identification bracelet (which is linked to that patient's computerized medical record), and then the drug bar code. The computer receiving the data will compare the scans to ensure a match. If there is a discrepancy, the computer will issue an error message. A match should ensure the patient gets the right dose, at the right time, administered the right way.

Veterans Administration hospitals using bar codes have already reduced medication errors by up to 85% over 5 years, says HHS.

“It is our hope that, by using the proven technology of scannable bar codes, we will be able to significantly reduce medication errors,” said Dr. John C. Nelson, president of the American Medical Association.

The bar code requirement “represents a tipping point in patient safety,” says Ned Simpson, chairperson of the Auto ID and Bar Coding Task Force of the Healthcare Information and Management Systems Society.

Some Canadian hospitals are using bar coding, though it's in its “early stages,” says Bonnie Salsman, board member of the newly established Canadian Patient Safety Institute. If appropriately integrated into the system, the practice, she says, does provide safety opportunities. — Milan Korcok, Lauderdale-by-the-sea, Fla.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 170 (11)
CMAJ
Vol. 170, Issue 11
25 May 2004
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
US adopts bar codes for drug products
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
US adopts bar codes for drug products
Milan Korcok
CMAJ May 2004, 170 (11) 1657; DOI: 10.1503/cmaj.1040617

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
US adopts bar codes for drug products
Milan Korcok
CMAJ May 2004, 170 (11) 1657; DOI: 10.1503/cmaj.1040617
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
  • A newborn requiring selective bronchial intubation
  • Does β-blocker prophylaxis improve survival after major noncardiac surgery?
Show more Synopsis

Similar Articles

Collections

  • Topics
    • Drugs: adverse reactions
    • Patient safety & quality improvement

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire